A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
City of Hope Medical Center
Ohio State University Comprehensive Cancer Center
BeiGene
Kyowa Kirin Co., Ltd.
Northwestern University
University of Nebraska
University of Nebraska
OncoSec Medical Incorporated
Stanford University
Karyopharm Therapeutics Inc
miRagen Therapeutics, Inc.
Rochester Skin Lymphoma Medical Group, PLLC
Novartis
Novartis
Eisai Inc.
Galderma R&D
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Eli Lilly and Company
Jonsson Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Celgene
Roswell Park Cancer Institute
University of Chicago
City of Hope Medical Center
Barbara Ann Karmanos Cancer Institute
Case Comprehensive Cancer Center
University of Texas Southwestern Medical Center
University of Washington
Wake Forest University Health Sciences
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
OHSU Knight Cancer Institute
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
UNC Lineberger Comprehensive Cancer Center
University of Washington
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
National Institutes of Health Clinical Center (CC)
Stanford University
Alliance for Clinical Trials in Oncology
Mayo Clinic
Boston Medical Center
Vanderbilt University
National Cancer Institute (NCI)